Sign In

Login

Password

Forgot Password ? Sign Up

ミドスタウリン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ミドスタウリン" in Japanese language version.

refsWebsite
Global rank Japanese rank
4nih.gov
4th place
24th place
2doi.org
2nd place
6th place
1clinicaltrials.gov
5,225th place
low place
1wikipedia.org
low place
low place

clinicaltrials.gov

  • 臨床試験番号 NCT00651261 研究名 "Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia" - ClinicalTrials.gov

doi.org

  • Fischer T, Stone RM, Deangelo DJ, Galinsky I, Estey E, Lanza C, Fox E, Ehninger G, Feldman EJ, Schiller GJ, Klimek VM, Nimer SD, Gilliland DG, Dutreix C, Huntsman-Labed A, Virkus J, Giles FJ (2010). “Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3”. J. Clin. Oncol. 28 (28): 4339-4345. doi:10.1200/JCO.2010.28.9678. PMID 20733134. 
  • Millward, M. J.; House, C.; Bowtell, D.; Webster, L.; Olver, I. N.; Gore, M.; Copeman, M.; Lynch, K. et al. (2006). “The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study”. Br. J. Cancer 95 (7): 829. doi:10.1038/sj.bjc.6603331. PMC 2360547. PMID 16969355. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360547/. 

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Fischer T, Stone RM, Deangelo DJ, Galinsky I, Estey E, Lanza C, Fox E, Ehninger G, Feldman EJ, Schiller GJ, Klimek VM, Nimer SD, Gilliland DG, Dutreix C, Huntsman-Labed A, Virkus J, Giles FJ (2010). “Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3”. J. Clin. Oncol. 28 (28): 4339-4345. doi:10.1200/JCO.2010.28.9678. PMID 20733134. 
  • Millward, M. J.; House, C.; Bowtell, D.; Webster, L.; Olver, I. N.; Gore, M.; Copeman, M.; Lynch, K. et al. (2006). “The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study”. Br. J. Cancer 95 (7): 829. doi:10.1038/sj.bjc.6603331. PMC 2360547. PMID 16969355. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360547/. 

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

wikipedia.org

en.wikipedia.org

  • 臨床試験番号 NCT00651261 研究名 "Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia" - ClinicalTrials.gov